Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

Watch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market ↗

October 09, 2025

Roche has a promising GLP-1 drug that is entering phase 3 trials.

FDA Greenlights Jazz and Roche's Zepzelca-Tecentriq for ES-SCLC Maintenance, Reshaping Lung Cancer Treatment Landscape

October 03, 2025

In a pivotal moment for oncology, the U.S. Food and Drug Administration (FDA) on October 2, 2025, granted approval for the innovative combination of Jazz Pharmaceuticals' (NASDAQ: JAZZ) Zepzelca...

89bio Stock Skyrockets After Roche’s $3.5B Buyout Offer: Retail Bullish, But A Wall Street Analyst Is Cautious ↗

September 18, 2025

Why Did 89bio Stock Nearly Double In Value Today? ↗

September 18, 2025

Big Pharma Eyes China: J&J And Roche Reportedly In Talks For Henlius’ Experimental Cancer Drug ↗

September 15, 2025

Novartis Rides Bullish Retail Mood, Roche Faces Gloom Amid Swiss-US Trade Concerns ↗

August 11, 2025

Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design

October 02, 2025

London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented...

Via TokenRing AI

Topics Artificial Intelligence

GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley ↗

September 29, 2025

Shares had broke out earlier this month, but have floundered at the lower boundary of the chart pattern.

Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet ↗

September 26, 2025

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de

Via Benzinga

Topics Government World Trade

Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now ↗

September 26, 2025

BigBear.ai is bigger than both of these AI-focused companies now. That could change.

Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America ↗

Topics Artificial Intelligence

September 25, 2025

On Wednesday, Eli Lilly & Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began.

Topics Government

Eli Lilly Ends Bimagrumab Obesity Study Weeks After Launch ↗

September 25, 2025

Via Benzinga

Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’ ↗

September 22, 2025

BTIG said Pfizer’s $7.3 billion Metsera acquisition sharpens its clinical updates and strategic optionality.

The pharmaceutical industry is currently witnessing a transformative battle for dominance in the burgeoning weight-loss drug market, with Eli Lilly (NYSE: LLY) firmly at the forefront. What was once a...

Big Pharma's Epicenter Shift: Eli Lilly and the Reshaping of the Weight-Loss Drug Market

September 22, 2025

Roche advances weight loss drug CT-388 to Phase III, boosts pipeline with major acquisitions.

Topics Economy Intellectual Property

Roche Targets Top Spot In Weight Loss Drug Market ↗

September 22, 2025

Via Benzinga

The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market

September 19, 2025

The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving...

The global healthcare industry is currently in the midst of a profound metamorphosis, characterized by a rapid influx of technological innovation, significant shifts in policy, and evolving patient...

Topics Artificial Intelligence Economy Intellectual Property

The Healthcare Horizon: Navigating Innovation, Policy Shifts, and Evolving Patient Care

September 19, 2025

The "Jimmy Kimmel Live" drama coincided with reports of tit-for-tat maneuvering between the FCC and corporations desperate for deal approval.

Topics Artificial Intelligence

Deal Dispatch: Need M&A Approval? FCC Chair Explains How To Get It ↗

September 19, 2025

Via Benzinga

Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push ↗

September 18, 2025

Roche is acquiring 89bio for $2.4 billion plus potential milestone payouts, bolstering its pipeline with late-stage MASH drug pegozafermin.

Via Benzinga

Roche Digs Into Obesity-Tied Diseases With $3.5 Billion 89bio Buyout ↗

September 18, 2025

The company is now focusing on MASH, a form of fatty liver disease common in people with obesity and type 2 diabetes.

The positives for this big drugmaker appear to outweigh the negatives.

1 Super Stock Down More Than 20% to Buy Hand Over Fist, According to Wall Street ↗

September 12, 2025

The company's DualityBio-partnered drug met the pre-specified bar for success in a pivotal study.

Topics Earnings Government World Trade

BioNTech Surges 10% On Promising Test Results For Its Cancer Smart Bomb ↗

September 05, 2025

BioNTech and DualityBio reported Phase 3 success for trastuzumab pamirtecan in HER2 breast cancer, setting stage for regulatory submission in China.

BioNTech Advances On Positive Phase 3 Breast Cancer Drug Data ↗

September 05, 2025

Via Benzinga

2 High-Yield Dividend ETFs You Can Buy With $200 in September and Hold Forever ↗

September 05, 2025

You don't need to be rich to begin building a passive income stream that could fuel your retirement dreams.

These Vanguard index funds offer diversified exposure to many of the most influential stocks in the world.

Topics ETFs Retirement Stocks

2 Brilliant Vanguard Index Funds to Buy With $1,000 in August and Hold Forever ↗

August 08, 2025

This weight loss drugmaker may be significantly undervalued right now.

Topics ETFs

This Biotech Stock Could Soar on Upcoming Clinical Data ↗

August 04, 2025

FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy treatment.

FDA Probes Death Of 8-Year-Old Who Received Sarepta's Elevidys ↗

July 28, 2025

Via Benzinga

Roche Bets Big On Alzheimer’s Prevention With New Trial As Duchenne Drug Setback Looms ↗

July 27, 2025

The pharma company is advancing a third late-stage study of its experimental Alzheimer’s drug trontinemab, which uses brain shuttle technology to bypass the blood-brain barrier and clear amyloid...

The Median Retirement Savings for American Households Is $87,000. Here Are 3 Incredible Stocks to Buy Now and Hold for Decades. ↗

July 26, 2025

You should probably be saving more, but even if you can't do that, you can get more out of the money you are able to save.